Benzinga | Sep 10, 2021 06:33AM EDT

Adagio Therapeutics Announces Expansion Of Patient Population In Global Phase 2/3 Clinical Trial Of ADG20 For The Prevention of COVID-19

https://investors.adagiotx.com/news-releases/news-release-details/adagio-therapeutics-announces-expansion-patient-population